Liz Wager: How should journals and universities liaise over problematic publications?

Here’s a CLUE … Journals have a responsibility not to mislead their readers. That seems pretty straightforward and uncontroversial, but achieving this lofty aim can be tricky. In order to do that, journals need to know if a research report is trustworthy. Peer review is the first step but we know it’s not perfect and, […]

Read More…

Liz Wager: How much of a conflict of interest is too much for a peer reviewer?

One of the conundrums of peer review is that reviewers need to be knowledgeable about the research being reported but shouldn’t have conflicts of interest. The trouble is that the best-qualified people are often too closely connected to either the research or the authors. This problem is amplified in small research fields and for journals […]

Read More…

Liz Wager: Research integrity—how can institutions balance discipline and support?

The suicide of Yoshiki Sasai is both tragic and shocking. Sasai was deputy director of the RIKEN Center for Developmental Biology, and a co-author of reports in Nature on the phenomenon of “stimulus-triggered acquisition of pluripotency” (or STAP), which were retracted. Although Sasai was not accused of misconduct himself, he was criticised in an institutional […]

Read More…

Liz Wager: The wrong sort of equality

A few years ago, I mused on Frank Wells’ observation that he’d never come across a female research fraudster. But now the RIKEN Institute in Japan has found Haruko Obokata guilty of misconduct for manipulating stem cell images, and this isn’t an isolated case. A quick look at the US Office of Research Integrity’s (ORI) […]

Read More…

Liz Wager: Why aren’t researchers told about reporting guidelines?

I recently gave a talk about guidelines to a group of postgraduate students at a well known, well resourced, and ancient university. The purpose of my talk was to explain the guidelines governing professional medical writers, as this was a careers day for biomedical researchers, who were considering a move into the world of medical […]

Read More…

Liz Wager: Trouble with retractions

Retracting unreliable publications can cause headaches for journal editors and a recent case illustrates why they can be so tricky. According to reports in the BMJ and Nature, the drug company GlaxoSmithKline (GSK) has requested the retraction of an article published in Nature Medicine in 2010 describing cell biology experiments funded by the company and […]

Read More…

Liz Wager: What is the UK’s framework for research integrity?

 An item in The Lancet last week (Godecharle et al. Lancet 2013;381:10097-8) bemoans the lack of a regulatory framework for research integrity in Europe. The confusion is neatly illustrated by a map categorising countries by how they handle misconduct. The UK falls into the second best category, along with Germany and Sweden, of countries that […]

Read More…